Please note the upcoming scheduling changes: We will begin closing for lunch on SATURDAYS and SUNDAYS between 1:30pm and 2pm: Please plan accordingly

Manténgase sano!

Resultados de su búsqueda "Nose Bleeds".

Resultados de noticias de salud - 1

More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show.

Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe platelet counts without serious bleeding episodes for at least a year, according to results published Dec. 9 in

  • Dennis Thompson HealthDay Reporter
  • |
  • December 12, 2025
  • |
  • Página completa